INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,463,922 | -47.5% | 141,174 | -32.3% | 0.00% | -40.0% |
Q2 2023 | $8,499,205 | +40.6% | 208,416 | +28.5% | 0.01% | +66.7% |
Q1 2023 | $6,046,536 | +11.3% | 162,236 | +4.2% | 0.00% | 0.0% |
Q4 2022 | $5,432,722 | -33.8% | 155,710 | +6.2% | 0.00% | -40.0% |
Q3 2022 | $8,208,000 | +55.3% | 146,666 | +43.6% | 0.01% | +66.7% |
Q2 2022 | $5,286,000 | -49.4% | 102,126 | -29.0% | 0.00% | -40.0% |
Q1 2022 | $10,448,000 | -51.9% | 143,763 | -21.8% | 0.01% | -50.0% |
Q4 2021 | $21,731,000 | -11.5% | 183,794 | +0.5% | 0.01% | -16.7% |
Q3 2021 | $24,545,000 | -10.7% | 182,963 | +7.7% | 0.01% | -7.7% |
Q2 2021 | $27,500,000 | +161.1% | 169,847 | +29.4% | 0.01% | +116.7% |
Q1 2021 | $10,532,000 | +74.9% | 131,217 | +18.5% | 0.01% | +50.0% |
Q4 2020 | $6,022,000 | +767.7% | 110,717 | +216.7% | 0.00% | – |
Q3 2020 | $694,000 | -61.6% | 34,965 | -59.3% | 0.00% | -100.0% |
Q2 2020 | $1,805,000 | +101.2% | 85,854 | +17.0% | 0.00% | 0.0% |
Q1 2020 | $897,000 | -49.6% | 73,394 | -39.5% | 0.00% | 0.0% |
Q4 2019 | $1,779,000 | +19.2% | 121,334 | +8.4% | 0.00% | 0.0% |
Q3 2019 | $1,493,000 | -59.3% | 111,937 | -50.1% | 0.00% | -50.0% |
Q2 2019 | $3,669,000 | +281.0% | 224,228 | +296.7% | 0.00% | +100.0% |
Q1 2019 | $963,000 | -88.9% | 56,521 | -91.1% | 0.00% | -83.3% |
Q4 2018 | $8,680,000 | -63.3% | 635,956 | -23.0% | 0.01% | -14.3% |
Q3 2018 | $23,642,000 | +38.2% | 826,102 | +32.1% | 0.01% | +40.0% |
Q2 2018 | $17,113,000 | +130.4% | 625,537 | +77.5% | 0.01% | +25.0% |
Q1 2018 | $7,429,000 | +828.6% | 352,364 | +744.1% | 0.00% | +300.0% |
Q4 2017 | $800,000 | -16.1% | 41,744 | +8.5% | 0.00% | 0.0% |
Q3 2017 | $954,000 | +121.9% | 38,465 | +42.6% | 0.00% | – |
Q2 2017 | $430,000 | +1620.0% | 26,966 | +1325.3% | 0.00% | – |
Q1 2017 | $25,000 | -56.1% | 1,892 | -57.4% | 0.00% | – |
Q4 2016 | $57,000 | +21.3% | 4,438 | +57.3% | 0.00% | – |
Q3 2016 | $47,000 | -72.0% | 2,821 | -64.4% | 0.00% | – |
Q2 2016 | $168,000 | – | 7,932 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |